Literature DB >> 24894520

Phenotyping of CYP450 in human liver microsomes using the cocktail approach.

Dany Spaggiari1, Laurent Geiser, Youssef Daali, Serge Rudaz.   

Abstract

The cocktail approach is an advantageous strategy used to monitor the activities of several cytochromes P450 (CYPs) in a single test to increase the throughput of in vitro phenotyping studies. In this study, a cocktail mixture was developed with eight CYP-specific probe substrates to simultaneously evaluate the activity of the most important CYPs, namely, CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and the CYP3A subfamily. After cocktail incubation in the presence of human liver microsomes (HLMs), the eight selected substrates and their specific metabolites were analyzed by ultra-high-pressure liquid chromatography and electrospray ionization quadrupole time-of-flight mass spectrometry. Qualitative and quantitative data were simultaneously acquired to produce an overview of the extended phase I biotransformation routes for each probe substrate in the HLMs and to generate phenotypic profiles of various HLMs. A comparison of the cocktail strategy with an individual substrate assay for each CYP produced similar results. Moreover, the cocktail was tested on HLMs with different allelic variants and/or in the presence of selective inhibitors. The results were in agreement with the genetic polymorphisms of the CYPs and the expected effect of the alterations. All of these experiments confirmed the reliability of this cocktail assay for phenotyping of the microsomal CYPs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24894520     DOI: 10.1007/s00216-014-7915-4

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  12 in total

1.  CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches.

Authors:  Mary A Davis; Dustyn A Barnette; Noah R Flynn; Anirudh S Pidugu; S Joshua Swamidass; Gunnar Boysen; Grover P Miller
Journal:  Chem Res Toxicol       Date:  2019-04-10       Impact factor: 3.739

2.  Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450.

Authors:  Sumit Bansal; Neha Maharao; Mary F Paine; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2020-06-25       Impact factor: 3.922

3.  CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

Authors:  Mary Alexandra Schleiff; Samantha Crosby; Madison Blue; Benjamin Mark Schleiff; Gunnar Boysen; Grover Paul Miller
Journal:  Biochem Pharmacol       Date:  2021-11-05       Impact factor: 5.858

4.  Chronic administration of caderofloxacin, a new fluoroquinolone, increases hepatic CYP2E1 expression and activity in rats.

Authors:  Li Liu; Ming-xing Miao; Ze-yu Zhong; Ping Xu; Yang Chen; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2016-02-01       Impact factor: 6.150

5.  In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice.

Authors:  Hui Li; John D Clarke; Anika L Dzierlenga; John Bear; Michael J Goedken; Nathan J Cherrington
Journal:  J Biochem Mol Toxicol       Date:  2016-10-06       Impact factor: 3.642

6.  Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam.

Authors:  Dustyn A Barnette; Mary A Schleiff; Arghya Datta; Noah Flynn; S Joshua Swamidass; Grover P Miller
Journal:  Toxicol Lett       Date:  2020-11-27       Impact factor: 4.372

7.  Hepatocyte-based flow analytical bioreactor for online xenobiotics metabolism bioprediction.

Authors:  M Helvenstein; S Hambÿe; B Blankert
Journal:  Nanobiomedicine (Rij)       Date:  2017-04-12

8.  Dataset from proteomic analysis of human liver, lung, kidney and intestine microsomes.

Authors:  Wei Song; Longjiang Yu; Zhihong Peng
Journal:  Data Brief       Date:  2018-03-30

9.  The Inhibitory Effect of Flavonoid Aglycones on the Metabolic Activity of CYP3A4 Enzyme.

Authors:  Darija Šarić Mustapić; Željko Debeljak; Željan Maleš; Mirza Bojić
Journal:  Molecules       Date:  2018-10-07       Impact factor: 4.411

10.  Panax ginseng Inhibits Metabolism of Diester Alkaloids by Downregulating CYP3A4 Enzyme Activity via the Pregnane X Receptor.

Authors:  Liang Yang; Yuguang Wang; Huanhua Xu; Guangyao Huang; Zhaoyan Zhang; Zengchun Ma; Yue Gao
Journal:  Evid Based Complement Alternat Med       Date:  2019-03-21       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.